You just read:

Health Canada Approves VIMOVO, the First NSAID-PPI Combination to Treat Osteoarthritis Pain and Inflammation While Reducing the Risk of NSAID-associated Ulcers

News provided by

AstraZeneca Canada Inc.

Apr 27, 2011, 08:00 ET